The trade of traditional Chinese medicine to South Korea has entered the best harvest period

Business News Agency September 14 August 18, the "China South Korea traditional Chinese medicine enterprise exchange forum" jointly organized by China Chamber of Commerce for the import and export of health care products, Chinese medicine delegation and Korea pharmaceutical import and export association was held in Seoul, South Korea, with nearly 20 enterprises from the Korean traditional Chinese medicine industry attending the meeting China and South Korea exchanged extensive views on such issues as "sulfur fumigation medicine and sulfur dioxide residue limit standard" According to the protection of the interests of both sides, at present, the imported medicinal materials in South Korea are mainly tested by the pharmaceutical testing institute under the Korean pharmaceutical import and export association and several other designated institutions in accordance with the regulations on the administration of imported pharmaceutical products The testing contents include three items of "functional test, precision test and hazardous substance test" In the past two years, with the efforts of the Korean pharmaceutical import and export association and related enterprises, the Korean food and drug safety agency is gradually revising some standards in the original regulations on the import of medicinal materials (announcement 2010-20) Liu Zhanglin, vice president of China Chamber of Commerce for the import and export of medical and health care products, proposed at the meeting that South Korea should take full account of the industrial status quo of Chinese herbal medicine planting and processing development when formulating or modifying the regulations on the import of medicinal materials, otherwise it will affect the interests of enterprises of both sides After that, the two sides also discussed various problems in the trade of medicinal materials between the two countries and reached a consensus Enterprises of the two countries also had extensive and in-depth exchanges, and both expressed their willingness to further cooperate Finally, Liu said that more Korean cosmetics and health products enterprises are welcome to actively explore the Chinese market The trade with South Korea continues to grow South Korea is strict in the import management of all kinds of proprietary drugs, and the registration of new drugs in South Korea needs greater financial support Therefore, China's trade with South Korea in traditional Chinese medicine mainly focuses on the export of extracts and herbs, accounting for 91% of China's export to South Korea From January to July 2011, China's exports of traditional Chinese medicine to South Korea amounted to US $71.82 million, an increase of 30% year on year, mainly due to the continuous growth of export prices Due to the limitations of natural conditions and land scale, most of the medicinal materials in South Korea are imported from China, except for a small number of self-produced medicinal materials in the market For example, the trade of medicinal materials between China and South Korea is restricted, which will not only cause losses to the enterprises of both sides, but also directly affect the basic medicines of the ordinary people in South Korea During this visit, the Chinese traditional medicine delegation made extensive and in-depth contacts with the Korean Association for the import and export of pharmaceutical products Both sides agreed that through the joint efforts of the two countries' associations, more exchanges and consultations should be conducted between the Chinese and Korean governments on the formulation of pharmaceutical standards, so as to further promote the development of bilateral trade in traditional Chinese medicine At the same time of the exchange between the two associations, the Chinese enterprises accompanying the delegation and the Korean enterprises also had contact and negotiation, and made considerable achievements Chengdu Tiandi Network Information Technology Co., Ltd and Bozhou Guoyitang Pharmaceutical Co., Ltd have found their own partners in South Korea, and are ready to open offices in South Korea in order to further develop the Korean market In recent years, the business of China Medical and Health Products Co., Ltd in Korea has been interrupted due to the change of personnel Through this investigation, the company has reestablished contact with the original Korean customers and conducted many business negotiations, which has achieved good results.